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The European red mite, Panonychus ulmi (Koch), is one of the major pests of apple trees 
worldwide. Cyclic keto-enol compounds such as spirodiclofen and spiromesifen are frequently 
used to control phytophagous spider mites in agricultural crops, including P. ulmi on apple trees. 
Spider mites, however, can rapidly develop resistance against acaricides and, in this study, 
multiple P. ulmi populations from apple orchards in Iran were monitored for spirodiclofen and 
spiromesifen resistance. The Urmia and Shahin Dej population showed the highest spirodiclofen 
resistance ratio (more than 150-fold) compared to the susceptible Ahar population. Toxicity 
bioassays also revealed the presence of moderate cross-resistance between spiromesifen and 
spirodiclofen, but not towards the chitin synthase inhibitor etoxazole. As a first step towards 
elucidating spirodiclofen resistance mechanisms, the role of detoxification enzymes (cytochrome 
P450 monooxygenases, carboxyl/choline esterases and glutathione S-transferases) was 
investigated by in vivo synergism and in vitro enzyme assays. PBO pretreatment synergized 
spirodiclofen toxicity in the populations of Urmia and Shahin Dej to a higher extent than in the 
susceptible Ahar population. Furthermore, enzyme activity measurements showed relatively 
higher activity of detoxifying enzymes in the resistant populations. In conclusion, increased 
detoxification is most likely underlying spirodiclofen resistance and results in limited cross-
resistance to spiromesifen.  
 Keywords: Insecticide resistance, Spirodiclofen, Spiromesifen, Cross-resistance, Synergism, 
Cytochrome P450 monooxygenase. 
 
1. Introduction 
Apple is one of the major agricultural productions worldwide (Golding & Jobling, 2012). 
There are many species of insects and mites that thrive in apple orchards and some can become 
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destructive to apple trees (Walker et al., 2017). The European red mite, Panonychus ulmi (Koch) 
(Acari: Tetranychidae) is an injurious mite of apple trees (Dekeyser, 2005). The species attacks 
about 147 host plants and is distributed in 71 countries around the world (Migeon & Dorkeld, 
2019). Acaricides play a vital role in the control of P. ulmi and closely related mites such as the 
citrus red mite, Panonychus citri, and the two-spotted spider mite, Tetranychus urticae (Van 
Leeuwen, et al., 2015). Resistance development to synthetic pesticides, however, is a major 
challenge in the chemical control of spider mites. Many factors lead to rapid development of 
acaricide resistance in spider mites including high fecundity rates, reproduction through 
arrhenotokous parthenogenesis, a short life cycle and the frequency of acaricide applications 
(Van Leeuwen & Dermauw, 2016; Van Leeuwen et al., 2015, 2010).  
Several chemical classes of acaricides with different modes of action have been discovered 
and used in control programs of mites (Sparks & Nauen, 2015; Van Leeuwen et al., 2015). 
Spirodiclofen and spiromesifen, two cyclic keto-enol compounds, have excellent acaricidal 
activity against phytophagous mites and a few pest insects (Dekeyser, 2005; Nauen et al., 2003). 
These acaricides inhibit acetyl-CoA carboxylase (ACCase) and interfere with the biosynthesis of 
lipids in insects and mites (Bretschneider et al., 2012). More specifically, Lümmen et al. (2014) 
showed that the enol metabolite of the related cyclic keto-enol insecticide, spirotetramat, 
inhibited T. urticae ACCase by interacting with the carboxyltransferase (CT) domain. A number 
of studies have investigated resistance in P. ulmi against acaricides such as clofentezine, dicofol, 
fenazaquin, tebufenpyrad, hexythiazox, pyridaben, fenpyroximate, abamectin and pyrethroids 
(Auger et al., 2003; Nauen et al., 2001; Pree et al., 2005; Rameshgar et al., 2019a; 2019b; 
Thwaite, 1991). Resistance to spirodiclofen has been documented in T. urticae, P. citri and P. 
ulmi (Demaeght et al., 2013; Kramer & Nauen, 2011; Ouyang et al., 2012; Rauch & Nauen, 
4 
 
2002; Van Pottelberge et al., 2009; Yu et al., 2011) while spiromesifen resistance has also been 
reported in Trialeurodes vaporariorum (Westwood) and Bemisia tabaci (Gennadius) (Bielza et 
al., 2019; Karatolos et al., 2012). Bielza et al. (2019) suggested the involvement of target-site 
insensitivity in resistance to spiromesifen and spirotetramat in B. tabaci, because of lack of a 
metabolic resistance mechanism. For spider mites, it has been shown that detoxification enzymes 
such as cytochrome P450 monooxygenases (P450s) are involved in spirodiclofen resistance, 
while carboxyl/choline esterases (CCEs) are much likely involved in sequestration of 
spirodiclofen (Demaeght et al., 2013; Kramer & Nauen, 2011; Wei et al., 2019, Bajda et al. 
2015). In a recent study, spirodiclofen resistance in T. urticae was also mapped to a number of 
genomic loci (Quantitative Trait Loci (QTL) mapping), with one of the QTLs containing the 
gene encoding ACCase, the target-site of spirodiclofen (Wybouw et al., 2019). In the ACCase 
gene of the resistant strain that was used for the mapping experiment, a non-synonymous 
mutation, A1079T, was also identified. This mutation, however, was located outside the CT-
domain of ACCase and awaits functional validation (Khajehali, 2010; Wybouw et al., 2019). 
Etoxazole, an acaricide from the oxazoline family, has been registered for spider mite control 
in Iran (Noorbakhsh et al., 2016). It acts as a mite growth inhibitor and inhibits chitin synthesis 
in embryonic and immature stages (Demaeght et al., 2014; Van Leeuwen et al., 2012). There are 
many reports of etoxazole resistance in spider mites (Adesanya, et al., 2018; Demaeght et al., 
2014; Herron et al., 2018; Lee et al., 2004; Wu et al., 2019). In T. urticae, an amino acid 
substitution of isoleucine to phenylalanine at position 1017 (I1017F) in the chitin synthase 1 
gene (CHS1) has been confirmed to confer strong etoxazole resistance (Demaeght et al., 2014; 




Spirodiclofen has been widely used in Iranian apple orchards since 2005, but there is no 
information on resistance development in Iranian populations of P. ulmi to this acaricide. 
Therefore, the aim of this study was to determine the status of resistance of European red mite 
populations to spirodiclofen, as an essential step in resistance management and population 
control. Cross-resistance levels between spirodiclofen, spiromesifen and etoxazole were also 
assessed. Furthermore, using in vivo and in vitro assays, we investigated the involvement of 
detoxification enzymes in the resistance development. 
 
2. Materials and methods 
2.1. Field populations of P. ulmi 
Eleven populations of P. ulmi were collected from East Azarbaijan (Mianeh, Marand, Ahar, 
and Maraqeh), West Azarbaijan  (Urmia, Salmas, Shahin Dej, and Mahabad) and Isfahan 
(Semirom) during 2016 and 2017 (Table 1). The field-collected populations were kept on leaf 
discs of Malus domestica var. Fuji, at 25 ±1°C, a photoperiod of 16:8h (light: dark), and 60% 
relative humidity (RH).  
 
2.2. Acaricides and chemical materials 
Bioassays were conducted with the commercial formulation of spirodiclofen (Envidor SC 
24%, Bayer CropScience), spiromesifen (Oberon SC 24%, Bayer CropScience) and etoxazole 
(Baroque SC11%, Sumitomo Chemical, Japan). The synergists including diethylmaleate (DEM) 
and piperonyl butoxide (PBO) were provided from Sigma-Aldrich (Bornem, Belgium), and 
triphenyl phosphate (TPP) was provided from Merck (Darmstadt, Germany). Bovine serum 
albumin was used as a standard for protein determination (Sigma Aldrich, USA). For enzyme 
assays analytical grades of 3,3',5,5'-tetramethylbenzidine (TMBZ) (Sigma Aldrich, USA), 
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cytochrome C (Merck, Germany) and 1- chloro-2,4-dinitrobenzene (CDNB) (Sigma Aldrich) 
were purchased. 
 
2.3. Toxicity assays on P. ulmi larvae 
Intoxication symptoms of spirodiclofen on adult spider mite females are less pronounced 
(Nauen, 2005), so spirodiclofen toxicity bioassays were performed with mite larvae. The 
bioassay method described by Van Leeuwen et al. (2004) was used, with slight modifications. 
Briefly, 20–30 adult female mites were transferred to the upper side of apple leaf discs (12.25 
cm2 square-cut) on wet cotton wool, and allowed to lay eggs for 12 hours, after which they were 
removed. Leaf discs were kept in a climatically controlled room at 25 ± 1°C, 60% RH and 16: 8 
h (light: dark) photoperiod. After larval emergence, leaf disks were sprayed with spray fluid 
(1.05 mL, 1.00 ± 0.03 mg aqueous acaricide deposit per cm2, at 1 bar pressure) using a Potter 
spray tower (Burkard Scientific Ltd, Uxbridge, UK). Serial dilutions of spirodiclofen, 
spiromesifen and etoxazole were used in toxicity tests and a minimum of three replicates per 
concentration were considered for each assay, and distilled water was sprayed instead of 
acaricide in the control. Mortality was assessed after 6 days when adults appeared in the control. 
All control mortalities were lower than 10%. LC50 values, slopes and 95% confidence intervals 
were calculated by probit regression analysis using the software POLO-Plus. Resistance ratios 
(RRs) were calculated by dividing the LC50 value of the resistant strain by the LC50 value of the 
most susceptible strain (Robertson et al., 2017).  
 
2.4. Synergism assays 
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Three synergists PBO, DEM and TPP are known as the inhibitors of P450s, glutathione-S-
transferases (GSTs) and carboxyl/choline esterases (CCEs), respectively. Resistant and 
susceptible populations were pre-treated with synergists for 4h before performing spirodiclofen 
toxicity tests as described above. Larvae were pre-treated with synergists, diluted first in acetone 
and then mixed with water. In the control, larvae were treated with water + acetone. Based on the 
preliminary tests, synergist concentrations of PBO 200 mg/L, DEM 400 mg/L and TPP 100 
mg/L caused less than 15% mortality on larvae. To estimate synergistic ratios (SRs) LC50 values 
of spirodiclofen were divided by LC50 values of spirodiclofen+ synergist (Van Pottelberge et al., 
2009). Synergistic ratios and resistance ratios were considered to be significantly different when 
their 95% confidence intervals did not overlap (Robertson et al., 2017). 
 
2.5. Enzymatic assays 
In order to determine in vitro enzyme activities of P450s, CCEs and GSTs, about fifty female 
mites were homogenized. P450 activity was estimated by measuring heme peroxidase activity, 
using 3,3',5,5'-tetramethylbenzidine (TMBZ) and cytochrome C as substrate and standard, 
respectively. The assay was conducted according to Brogdon et al. (1997). Briefly, the total 
reaction volume was 650 μL, consisting of enzyme source (40 μL containing about 5.25µg 
protein), potassium phosphate buffer (160 μL, 0.625 M, pH 7.2), 50 μL H2O2 (3%) and 400 μL 
of TMBZ solution (0.01 g of TMBZ in 5 mL methanol plus 15 mL of 0.25 M sodium acetate 
buffer, pH 5.0). The reactions were incubated at room temperature for 2 h. The optical density 
was measured at 450 nm based on Tiwari et al. (2011) by using a Unico 1200 Spectrophotometer 
(UNICO, Dayton, USA).  
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Esterase activity was determined using α-naphthyl acetate (α-NA) (6.4 mM) as the substrate 
(diluted in phosphate sodium buffer 0.2 M, pH 7) according to the method of Van Leeuwen et al. 
(2006). Enzyme samples (30 μL) were added to α-NA (200 μL), Fast Blue RR 0.2% (120 μL) 
and phosphate sodium buffer (0.2 M, pH 7, 200 μL). Finally, absorbance was read at 450 nm 
every 30 s for 5 min by using a Unico 1200 Spectrophotometer (UNICO, Dayton, USA). 
The activity of GSTs was measured using CDNB as substrate, based on the method of Habig 
et al. (1974). Enzyme samples (25 μl) were added to 200 μl of CDNB and 200 μl of reduced 
glutathione (GSH; 10 mM). Then, absorbance was read at 340 nm every 30 sec for 5 min using a 
Unico 1200 Spectrophotometer (UNICO, Dayton, USA). 
All protein concentrations were measured with a Coomassie protein assay according to the 
method of Bradford (1976), and bovine serum albumin (Sigma Aldrich, USA) was used as 
standard. Thirty μl of enzyme sample was mixed with 470 μl of Bradford reagent then incubated 
for 5 min at room temperature and absorbance was measured at 590 nm using a Unico 1200 
Spectrophotometer (UNICO, Dayton, USA).  
Each enzyme test was performed in three replicates. Data represent the mean values of three 
replicates with the standard error. Analysis of variance (ANOVA) followed by Fisher's protected 
Least Significant Difference (LSD) mean separation tests was used to determine significant 
differences in the level of detoxifying enzyme activity between resistant and susceptible 
populations (GLM Procedure in SAS/STAT version 9.4). 
 
3. Results 
3.1. Resistance and cross-resistance in P. ulmi populations 
Results of spirodiclofen toxicity against European red mite larvae are shown in Table 2. The 
Ahar population was found as the most susceptible population to spirodiclofen, with an LC50 
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value of 2.05 mg active ingredient per liter (mg a.i. L-1). Populations of Urmia and Shahin Dej 
were most resistant to spirodiclofen with LC50 values of 443 and 306 mg a.i. L
-1, respectively. 
Strains Marand, Salmas, Meianeh 2 and Maragheh showed moderate resistance levels with 
resistance ratios of 20-, 16-, 15- and 11-fold, respectively (Table 2). 
Urmia and Shahin Dej populations were found 22.2- and 21.7-fold resistant to spiromesifen, 
respectively (Table 2). There was a strong correlation between log10 LC50 values of spirodiclofen 
and spiromesifen (r =0.96 and p= 0.0001). The Urmia and Shahin Dej populations were 6.71- 
and 11.8-fold resistant to etoxazole, respectively (Table 3). There was a relatively weak 
correlation between log10 LC50 values of spirodiclofen and etoxazole (r = 0.79 and p= 0.018). 
Similarly, the correlation between log10 LC50 values of spiromesifen and etoxazole was also 
week (r = 0.8 and p= 0.017) 
 
3.2. Synergism studies 
Results of synergism studies using PBO, TPP, and DEM on selected resistant and susceptible 
populations are given in Table 4. Pretreatment with PBO significantly synergized spirodiclofen 
toxicity in resistant Shahin Dej and Urmia populations, but not in the susceptible Ahar 
population. Pretreatment with DEM and TPP had no significant effect on spirodiclofen toxicity 
in the tested populations. 
 
3.3. Enzymatic assays 
Detoxification enzyme activities in some resistant and susceptible populations are presented 
in Table 5. The P450 activity in the resistant population of Urmia was significantly higher when 
compared to strain Ahar (2.01-fold). In addition, significant differences in CCE activity were 
observed between the susceptible and resistant populations. Esterase activities in Shahin Dej and 
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Urmia populations were found 1.28 and 1.84 times higher compared to Ahar, respectively. The 
activities of GSTs in the Shahin Dej and Urmia populations were estimated 3.08 and 3.54 times 
higher when compared to strain Ahar, respectively. 
 
4. Discussion 
European red mite has developed resistance to most classes of acaricides (Mota-Sanchez & 
Wise, 2019). Tetronic acid acaricides such as spirodiclofen and spiromesifen, and chitin 
synthase-1 (CHS-1) inhibitors like etoxazole, have high activity on juvenile stages of mites 
(Demaeght et al., 2014; Sparks & Nauen, 2015; Van Leeuwen et al., 2012, 2015), and have been 
used extensively to control mites of agricultural importance (Van Leeuwen et al., 2015). 
Development of resistance to acaricides and insecticides is one of the major problems for 
sustainable chemical control measures of pests (Hemingway, 2018; Van Leeuwen & Dermauw, 
2016; Van Leeuwen et al., 2010). There are a number of reports on resistance to spirodiclofen, 
spiromesifen, and etoxazole in spider mites, especially in T. urticae (Demaeght et al., 2014; 
Ferreira et al., 2015; Herron et al., 2018; Kramer & Nauen, 2011; Lee et al., 2004; Van Leeuwen 
& Dermauw, 2016; Wu et al., 2019). However, very few studies have been conducted on 
monitoring and characterization of P. ulmi resistance to spirodiclofen (Bajda et al., 2015; Kramer 
& Nauen, 2011). 
In this study, eleven populations were collected and tested from three important areas of 
Iranian apple production. The results indicated high spirodiclofen resistance levels in strains 
collected in Urmia and Shahin Dej, exhibiting resistance ratios of 217- and 149-fold, respectively 
(Table 2). Such a high resistance level to spirodiclofen has also been reported in some laboratory 
selected strains of T. urticae and P. ulmi (Demaeght et al., 2013; Rauch & Nauen, 2002; Van 
Pottelberge et al., 2009), but up till now, has only been found in Brazilian field populations of T. 
11 
 
urticae (Demaeght, 2015; Hu et al., 2010; Kramer & Nauen, 2011; Rauch & Nauen, 2002; Van 
Pottelberge et al., 2009, Ferreira et al. 2015). Previous studies have reported a 60-fold 
spirodiclofen resistance ratio in field-collected populations of P. ulmi. However, this resistance 
ratio increased to 7000-fold by laboratory selection, indicating the strong potential of P. ulmi to 
develop resistance levels compromising the field-efficacy of recommended label rates (Kramer 
& Nauen, 2011).  
Cross resistance between acaricides targeting immature stages, such as spirodiclofen, 
spiromesifen and etoxazole, is another challenge for the implementation of resistance 
management strategies in the field (Kramer & Nauen, 2011; Van Pottelberge et al., 2009; Wu et 
al., 2019). Bioassays with spiromesifen, another tetronic acid acaricide, indicated that 
spirodiclofen resistant populations were moderately cross-resistant to spiromesifen: the 
populations collected in Urmia and Shahin Dej exhibited a 22- and 21-fold resistance to 
spiromesifen, respectively (Table 2). A strong correlation was found between spirodiclofen 
resistance and resistance to spiromesifen in P. ulmi populations, suggesting cross resistance 
between these compounds. However, spiromesifen is not registered for spider mite control in 
apple orchards in Iran (Noorbakhsh et al., 2016). Resistance ratios against spiromesifen (about 
20-fold) were moderate compared to spirodiclofen resistance ratios (more than 150-fold), but are 
similar to those reported for a spirodiclofen resistant strain of P. ulmi (PSR-TK) (Kramer & 
Nauen, 2011) and a spirodiclofen resistant strain of T. urticae (SR-VP) (Van Pottelberge et al., 
2009). In addition, cross resistance between spirodiclofen and spirotetramat, another inhibitor of 
ACCase, has also been reported in P. citri (Yu et al., 2011).  
The LC50 values and RRs of tested P. ulmi populations against etoxazole, a mite growth 
inhibitor acting on chitin synthase-1, showed that spirodiclofen resistant populations of Shahin 
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Dej and Urmia were 11- and 6-fold resistant to etoxazole, respectively. Correlation analysis of 
spirodiclofen and etoxazole indicated a relatively weak correlation between spirodiclofen 
resistance and etoxazole resistance. Because of this weak correlation and the fact that etoxazole 
is also registered for spider mite control in Iran (Noorbakhsh et al., 2016), it is not clear whether 
this low etoxazole resistance is caused by elevated levels of detoxification enzymes targeting 
spirodiclofen, or if it has been selected in the field by frequent etoxazole applications. True 
cross-resistance is only possible by metabolic mechanisms as both compounds have a different 
mode of action. Nevertheless, considering the low levels of resistance, etoxazole still seems a 
viable alternative for spirodiclofen in regions where spirodiclofen resistance has been reported. 
Two mechanism have been associated with resistance to cyclic keto-enols in insects and mites 
(Demaeght et al., 2013; Karatolos et al., 2012), including point mutations in ACCase (Karatolos 
et al., 2012; Wybouw et al., 2019), and metabolic resistance via enhanced P450 or CCE activity 
(Demaeght et al., 2013; Wei et al., 2019; Pan et al., 2018). ACCase mutations E645K and 
A1079T reported by Karatolos et al. (2012) and Wybouw et al. (2019), respectively, are located 
outside the CT domain where cyclic ketoenols bind and are unlikely to confer the observed 
levels of resistance. In this study, we investigated metabolic resistance of P. ulmi populations to 
cyclic keto-enols using synergistic assays and in vitro measurement of detoxification enzyme 
activities.The synergist PBO increased spirodiclofen toxicity about 2- and 3-fold in the Urmia 
and Shahin Dej population, respectively. Similarly, in a highly spirodiclofen resistant strain of P. 
ulmi (RR= 7000-fold), it has been reported that toxicity of spirodiclofen increased by 
approximately 3-fold after pretreatment with PBO (Kramer & Nauen, 2011). Furthermore, P450 
activity in the Urmia population was estimated 2 times higher than that of the Ahar population. 
This is much less than the 11-fold higher P450 activity found in a spirodiclofen resistant T. 
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urticae strain (Van Pottelberge et al., 2009). In the latter study a different enzyme assay was used 
(using 7-ethoxy-4-trifluoromethylcoumarin as substrate), so a direct comparison to our data is 
difficult because the TMBZ assay measures heme content rather than true P450 activity. TPP 
pretreatment on resistant populations did not significantly enhance toxicity of spirodiclofen in 
the Urmia and Shahin Dej population. Similarly, another esterase inhibitor, DEF (S,S,S-tributyl 
phosphorotrithioate), had no effect on spirodiclofen toxicity in a spirodiclofen resistant strain 
(PSR-TK) of P. ulmi (Kramer & Nauen, 2011). In contrast, synergism and enzymatic assays 
have previously pointed out the involvement of CCEs in spirodiclofen resistance in spider mites 
(Van Pottelberge et al., 2009), which was subsequently linked to the overexpression of a single 
esterase isozyme (Wei et al., 2019). Considering the significantly higher activity levels of 
esterases found in Urmia and Shahin Dej populations compared to the Ahar population (Table 5), 
the potential involvement of CCEs in spirodiclofen resistance in Iranian P. ulmi populations 
cannot be ruled out. Based on the synergism assays, spirodiclofen toxicity was not affected by 
DEM pretreatment in the Shahin Dej and Urmia population. Similarly, in other P. ulmi and T. 
urticae populations resistant to spirodiclofen, DEM did not synergize spirodiclofen toxicity 
(Kramer & Nauen, 2011; Van Pottelberge et al., 2009). However, in line with Van Pottelberge et 
al., 2009, a significantly higher (more than 3-fold) GST activity was found in the Urmia and 
Shahin Dej population. As the synergist DEM depletes glutathione and thereby, much likely, 
inhibits all GSTs, the higher GST activity found in spirodiclofen resistant strains might not be 
related to spirodiclofen resistance, but potentially other compounds. 
Given the moderate cross-resistance between spiromesifen and spirodiclofen it seems rather 
unlikely that target-site resistance is involved. Furthermore, the synergism of spirodiclofen 
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toxicity with PBO is fairly high, thus rendering target-site resistance unlikely, too. Nevertheless, 
to exclude any contribution of target-site resistance the ACCase gene should be sequenced.  
To conclude, the present study showed that some field populations in Iran are highly resistant 
to spirodiclofen and showed moderate levels of cross resistance to spiromesifen. Synergistic 
assays and enzymatic assays indicated that cytochrome P450 monooxygenases and CCEs are 
likely to be involved in spirodiclofen resistance. Further investigations are necessary to more 
precisely elucidate which genes are involved in P. ulmi resistance to cyclic keto-enols. 
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Table 1. Sampling date and geographic	origin of P. ulmi Populations collected from Iran 
Latitude and 
longitude 








Adults 2017/6/7  Semirom1 
36°45′47″N 
 45°43′20″E 
Adults 2017/6/7  Semirom2 
36°45′47″N  
45°43′20″E









Adults 2017/7/13 Mianeh2 
38°11′41″N 
 44°45′53″E
Adults 2017/7/3  Salmas 
38°25′58″N 
 45°46′30″E 
Adults 2017/7/13 Marand 
36°40′45″N 
 46°34′01″E
Adults/nymphs 2016/7/12Shahin dej 
37°33′19″N 
 45°04′21″E




Table 2. Log-dose probit-mortality data for tetronic acid acaricides tested against larvae of P. 
ulmi field populations. 
RR** 
(Cl 95%)*** 
χ2 (df) Slope±SE 





 2.90 (4) 1.52 ± 0.26 2.05 (0.87 -3.38) 356 Ahar Spirodiclofen 
149 (69.6 – 321) 1.22 (5) 1.11 ± 0.14 306 (185 -449) 451 Shahin Dej  
2.32 (1.08 – 5.01) 1.58 (4) 1.44 ± 0.19 4.76 (2.81 -6.95) 438 Mahabad  
3.45 (1.62 – 7.34) 0.44 (4) 1.49 ± 0.25 7.06 (4.15 -10.1) 298 Mianeh1  
1.19 (0.6 – 2.38) 2.09 (4) 1.25 ± 0.13 2.44 (1.77 -3.16) 417 Semirom1  
1.36 (0.71 – 2.63) 1.15 (3) 1.64 ± 0.2 2.79 (2.31 -3.41) 387 Semirom2  
217 (94.1 – 498) 7.61 (9) 0.83 ± 0.10 443 (243 -737) 425 Urmia  
16.4 (8.19 – 33.0) 0.47 (3) 1.90 ± 0.27 33.6 (23.9 -44.3) 197 Salmas  
20.6 (9.78 – 43.2) 2.31 (6) 1.07 ± 0.15 42.0 (27.2 -61.3) 516 Marand  
11.1 (5.63 – 21.8) 0.25 (3) 1.92 ± 0.25 22.7 (17.2 -28.5) 228 Maraqeh  
15.9 (7.37 – 34.2) 2.69 (3) 1.41 ± 0.24 32.5 (19.0 -48.2) 309 Mianeh2  
 0.21 (3) 1.24 ± 0.34 0.30 (0.12 – 0.56) 194 Ahar Spiromesifen 
21.7 (10.8 – 43.4) 1.20 (3) 2.51 ± 0.37 6.60 (5.05 – 8.18) 219 Shahin Dej  
1.30 (0.55 – 3.04) 0.51 (3) 1.38 ± 0.32 0.40 (0.21 – 0.69) 225 Mahabad  
1.32 (0.66 – 2.66) 2.05 (3) 1.24 ± 0.34 0.40 (0.30 – 0.50) 466 Mianeh1  
1.15 (0.58 – 2.27) 0.66 (2) 2.25 ± 0.30 0.35 (0.28 – 0.42) 356 Semirom1  
1.28 (0.57 – 2.87) 0.23 (3) 1.30 ± 0.26 0.39 (0.22 – 0.62) 202 Semirom2  
22.2 (10.9 – 45.4) 1.79 (2) 2.53 ± 0.56 6.77 (4.84 – 9.10) 164 Urmia  
3.02 (1.43 – 6.36) 1.60 (4) 1.20 ± 0.17 0.92 (0.63 – 1.30) 430 Salmas  
7.19 (3.12 – 16.1) 0.31 (3) 1.51 ± 0.28 2.19 (1.15 – 3.23) 185 Marand  
5.85 (2.74 – 12.5) 1.07 (2) 1.62 ± 0.38 1.78 (1.14 – 2.65) 189 Maraqeh  
2.91 (1.35 – 6.29) 0.39 (2) 1.62 ± 0.40 0.89 (0.55 – 1.37) 171 Miyaneh2  
*Number of mites tested. 
** Resistance ratio = LC50/LC50 Ahar. 
***Confidence interval.  
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Table 3. Log-dose probit-mortality data for a mite growth inhibitor acaricide (etoxazole) 
tested against the larvae of P. ulmi field populations. 
RR** 
(Cl 95%)*** 
χ2 (df) Slope±SE 




 0.93 (3) 1.15 ± 0.26 0.30 (0.16 – 0.46) 254 Ahar 
11.8 (6.72 – 20.9) 0.62 (2) 0.37 ± 1.89 3.51 (2.44 – 4.67) 220 Shahin Dej 
4.94 (1.98 – 12.3) 0.61 (4) 0.33 ± 1.12 1.46 (0.49 – 3.25) 182 Mahabad 
2.45 (1.31 – 4.54) 1.04 (3) 0.34 ± 1.74 0.72 (0.44 – 1.03) 250 Mianeh 1 
1.03 (0.56 – 1.90) 0.61 (2) 0.31 ± 1.55 0.30 (0.18 – 0.41) 286 Semirom 1 
2.59 (1.39 – 4.79) 0.99 (3) 0.53 ± 2.18 0.77 (0.43 – 1.05) 296 Semirom 2 
6.71 (3.61 – 12.5) 0.01 (3) 0.44 ± 2.46 1.99 (1.20 – 2.77) 220 Urmia 
14 (7.21 – 27.1) 1.57 (3) 0.27 ± 1.32 4.14 (2.38 – 6.36) 217 Marand 
*Number of mites tested. 
** Resistance ratio = LC50/LC50 Ahar. 
***Confidence interval.  
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Table 4. Synergistic effect of PBO (200 mg L-1), TPP (100 mg L-1), and DEM (400 mg L-1) on 




(CI 95%)***  
χ2 (df) Slope±SE 
LC50 mg a.i. l
-1  
(CI 95%) 
N*   
      Ahar 
  2.90 (4) 1.52±0.26 2.05 (0.88- 3.38) 356 Spirodiclofen 
1.25 (0.54 – 2.86)  0.53 (4) 1.27±0.27 1.64 (0.83–2.72) 189 +PBO 
0.90 (0.38 – 2.13)  0.50 (4) 1.24±0.28 2.27 (1.11–4.04) 213 +DEM 
0.99 (0.40 – 2.43)  0.19 (3) 1.04±0.29 2.07 (1.00–4.51) 159 +TPP 
        Shahin Dej 
 149 (69.6-321) 1.22 (5) 1.11±0.14 306 (185–449) 451 Spirodiclofen 
3.05 (1.60 – 5.80)  61.2 (126 -29.8) 0.12 (3) 1.78±0.29 100 (53.3–147) 392 +PBO 
0.90 (0.45 – 1.81) 150 (333 -67.2) 0.20 (3) 1.06±0.26 340 (174–595) 176 +DEM 
1.27 (0.62 – 2.58) 117 (274 -49.7) 0.21 (3) 1.44±0.34 241.2 (109–393) 139 +TPP 
      Urmia 
 216 (94.1-498) 7.61 (9) 0.83±0.10 443 (243–737) 425 Spirodiclofen 
2.15 (1.03–4.46) 126 (60.8-260) 0.99 (4) 1.10±0.20 206 (115–323) 288 +PBO 
0.96 (0.46–2.03) 202 (93.7-437) 0.33 (3) 1.64±0.40 460 (226–713) 124 +DEM 
1.40 (0.67–2.94) 153 (67.9-345) 0.57 (3) 1.21±0.29 316 (163–504) 234 +TPP 
*Number of mites tested. 
** Resistance ratio = LC50/LC50 Ahar. 
***Confidence interval. 
****Synergistic ratio.  
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Table 5. Detoxification enzyme activities in different populations of P. ulmi (mean ± SEM). 
Ratio  
Esterases  
α-Naphthyl Acetate***  
Ratio  
GSTs 





 4614 ± 1.96c  67.8 ± 3.63b  11.6 ± 0.31b Ahar 
1.28 5891 ± 82.1b 3.08 209 ± 4.42a 0.67 7.84 ± 4.42b Shahin Dej 
1.84 8507 ± 297a 3.54 240 ± 29.9a 2.01 23.3 ± 1.97a Urmia 
* Equivalent units of cytochrome P450 mg-1 protein (± SEM). 
**nmol glutathione conjugated min-1 mg-1 protein (± SEM). 
***nmol 1-naphthol min-1 mg-1 protein (± SEM). 
Significant differences are indicated by different letters within the columns (one-way ANOVA, p < 0. 05; LSD test). 
